These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 35756670)
1. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. Li XY; Pi YN; Chen Y; Zhu Q; Xia BR Front Oncol; 2022; 12():894744. PubMed ID: 35756670 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation. Roberti A; Fernández AF; Fraga MF Mol Metab; 2021 Mar; 45():101165. PubMed ID: 33453420 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro. Pozzi V; Molinelli E; Campagna R; Serritelli EN; Cecati M; De Simoni E; Sartini D; Goteri G; Martin NI; van Haren MJ; Salvolini E; Simonetti O; Offidani A; Emanuelli M Hum Cell; 2024 May; 37(3):729-738. PubMed ID: 38504052 [TBL] [Abstract][Full Text] [Related]
4. Qian Yang Yu Yin Granule protects against hypertension-induced renal injury by epigenetic mechanism linked to Nicotinamide N-Methyltransferase (NNMT) expression. Zhang SF; Mao XJ; Jiang WM; Fang ZY J Ethnopharmacol; 2020 Jun; 255():112738. PubMed ID: 32147479 [TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-methyltransferase (NNMT): A key enzyme in cancer metabolism and therapeutic target. Sun WD; Zhu XJ; Li JJ; Mei YZ; Li WS; Li JH Int Immunopharmacol; 2024 Dec; 142(Pt B):113208. PubMed ID: 39312861 [TBL] [Abstract][Full Text] [Related]
6. Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells. Bach DH; Kim D; Bae SY; Kim WK; Hong JY; Lee HJ; Rajasekaran N; Kwon S; Fan Y; Luu TT; Shin YK; Lee J; Lee SK Mol Ther Nucleic Acids; 2018 Jun; 11():455-467. PubMed ID: 29858080 [TBL] [Abstract][Full Text] [Related]
7. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update. Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880 [TBL] [Abstract][Full Text] [Related]
8. Covalent inhibitors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ. Lee HY; Suciu RM; Horning BD; Vinogradova EV; Ulanovskaya OA; Cravatt BF Bioorg Med Chem Lett; 2018 Sep; 28(16):2682-2687. PubMed ID: 29731364 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119 [TBL] [Abstract][Full Text] [Related]
10. Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer. Cao L; Wu W; Deng X; Peng Y; Chen Y; Guo H; Wang L; Li X; Zhang Z; Shao Z Front Genet; 2022; 13():1000515. PubMed ID: 36386816 [TBL] [Abstract][Full Text] [Related]
11. Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer. Couto JP; Vulin M; Jehanno C; Coissieux MM; Hamelin B; Schmidt A; Ivanek R; Sethi A; Bräutigam K; Frei AL; Hager C; Manivannan M; Gómez-Miragaya J; Obradović MM; Varga Z; Koelzer VH; Mertz KD; Bentires-Alj M EMBO J; 2023 Jul; 42(13):e112559. PubMed ID: 37259596 [TBL] [Abstract][Full Text] [Related]
12. Development of fluorescence polarization-based competition assay for nicotinamide N-methyltransferase. Iyamu ID; Huang R Anal Biochem; 2020 Sep; 604():113833. PubMed ID: 32622979 [TBL] [Abstract][Full Text] [Related]
13. Nicotinamide N-methyltransferase and liver diseases. Liang G; Li Y; Lin Y; Yang X; Yang J; Hu S; Liu A Genes Dis; 2023 Sep; 10(5):1883-1893. PubMed ID: 37492717 [TBL] [Abstract][Full Text] [Related]
14. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer. Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726 [TBL] [Abstract][Full Text] [Related]
15. Targeting nicotinamide N-methyltransferase overcomes resistance to EGFR-TKI in non-small cell lung cancer cells. Wang J; Liu X; Huang Y; Li P; Yang M; Zeng S; Chen D; Wang Q; Liu H; Luo K; Deng J Cell Death Discov; 2022 Apr; 8(1):170. PubMed ID: 35387964 [TBL] [Abstract][Full Text] [Related]
16. Nicotinamide N-methyl transferase and cancer-associated thrombosis: insights to prevention and management. Jabbari P; Ardakany MR; Ebrahimi S; Rezaei N Epigenomics; 2023 Mar; 15(6):385-395. PubMed ID: 37212051 [TBL] [Abstract][Full Text] [Related]
17. Complex roles of nicotinamide N-methyltransferase in cancer progression. Wang W; Yang C; Wang T; Deng H Cell Death Dis; 2022 Mar; 13(3):267. PubMed ID: 35338115 [TBL] [Abstract][Full Text] [Related]
18. Bisubstrate Inhibitors of Nicotinamide Gao Y; van Haren MJ; Moret EE; Rood JJM; Sartini D; Salvucci A; Emanuelli M; Craveur P; Babault N; Jin J; Martin NI J Med Chem; 2019 Jul; 62(14):6597-6614. PubMed ID: 31265285 [TBL] [Abstract][Full Text] [Related]
19. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect. Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570 [TBL] [Abstract][Full Text] [Related]
20. Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells. Xie X; Yu H; Wang Y; Zhou Y; Li G; Ruan Z; Li F; Wang X; Liu H; Zhang J Arch Biochem Biophys; 2014 Dec; 564():52-66. PubMed ID: 25201588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]